What’s New in Photon Counting CT?

October 11, 2026 · 4 articles · 5 research themes · covering October 04, 2026 – October 11, 2026

Overview

Across these recent papers, photon-counting/spectral CT emerges as a central technical theme, with studies and reviews highlighting how detector advances can translate into more quantitative, material-specific imaging. In oncology, photon-counting CT (PCD-CT/PCCT) is positioned as a way to address limitations of energy-integrating dual-energy approaches—especially low-keV noise and workflow complexity—while enabling clinically relevant outputs such as virtual monoenergetic imaging, iodine mapping, and material decomposition to improve tumor conspicuity and local extent assessment.

Complementing the hardware-focused work, the digest also emphasizes that “what you image” depends strongly on protocol design. A narrative review on elective oncologic imaging underscores that contrast agent selection and, critically, timing/phase selection influence lesion detection and characterization across CT and MRI, pointing to a need for better standardization of contrast-phase protocols in real-world practice.

Finally, the set broadens spectral/quantitative CT beyond tumors into cardiothoracic and musculoskeletal applications. A cardiothoracic expert panel review suggests that PCD-CT’s improved spatial/contrast resolution and intrinsic spectral information may reduce radiation and contrast-media requirements, while a prospective study validates PCCT-derived vertebral bone marrow adipose tissue metrics against MRI proton density fat fraction—supporting the use of CT-based, MRI-referenced quantitative biomarkers for marrow fat assessment in low back pain and related metabolic conditions.

---

Quantitative Imaging Biomarkers (CT/MRI-Referenced)

Quantitative assessment of vertebral bone marrow adipose tissue using photon-counting CT compared with MRI.

This prospective study evaluated photon-counting CT (PCCT)–derived quantitative parameters for vertebral bone marrow adipose tissue (BMAT) in adult participants with low back pain, using MRI proton density fat fraction (PDFF) from a 6-echo q-Dixon sequence as the reference standard. It found that PCCT measures—including virtual non-calcium (VNCa) CT values, VNCa CT fat fraction (CTFF), and standardized 70 keV CT values—showed correlation and agreement with MRI PDFF at both vertebral and subject levels. The scientific significance is that PCCT can provide an MRI-referenced, quantitative alternative for assessing BMAT composition, potentially enabling more accessible evaluation of marrow fat changes relevant to musculoskeletal and metabolic conditions.

Shu D, Wang J, Liang D et al. · European journal of radiology · (2026) · View on PubMed ↗

---

Oncologic Imaging: Tumor Characterization & Staging

Practical applications of photon-counting CT in oncology: an organ-based pictorial review.

This organ-based review studied how photon-counting CT (PCD-CT) and related spectral CT approaches (including energy-integrating detector CT dual-energy CT) can be applied to oncologic imaging in clinical practice. It found that PCD-CT can overcome key limitations of EID-CT-based dual-energy methods—namely increased low-keV noise and added workflow complexity—while enabling material-specific imaging such as low-keV virtual monoenergetic imaging, iodine mapping, and material decomposition to improve tumor conspicuity and local extent assessment. The significance is that PCD-CT may broaden the clinical adoption of spectral, quantitative tumor characterization beyond conventional contrast-enhanced CT by improving image quality and potentially reducing contrast and/or radiation dose.

Kawasaki Y, Yokoyama K, Hada H et al. · Insights into imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

Contrast Agent Selection & Imaging Protocol Optimization

[Contrast agent strategies in elective oncological imaging].

This narrative review studied contrast agent strategies for elective oncological imaging, focusing on how intravenous contrast selection and timing affect CT and MRI staging, treatment planning, and response assessment across tumor entities. It found that while guidelines specify imaging frequency and modality, real-world protocol implementation varies, and that choosing the appropriate contrast phase is crucial for detecting and characterizing intraparenchymal lesions. The clinical significance is improved standardization and optimization of contrast-phase protocols to enhance lesion conspicuity and diagnostic accuracy in routine oncologic imaging.

Gerwing M, Eisenblätter M · Radiologie (Heidelberg, Germany) · (2026) · View on PubMed ↗

---

Cardiothoracic Imaging Applications

Photon-Counting Detector CT in Cardiothoracic Imaging: AJR Expert Panel Narrative Review.

This AJR expert panel narrative review studied the clinical impact of photon-counting detector CT (PCD-CT) versus conventional energy-integrating detector CT (EID-CT) in cardiothoracic imaging. It found that PCD-CT provides improved spatial and contrast resolution with intrinsic spectral information, with potential benefits including reduced radiation dose and reduced contrast-media volume for pulmonary and cardiac assessment. The significance is that these technical advantages may translate into better visualization of cardiopulmonary anatomy and more efficient, safer imaging workflows in clinical cardiothoracic practice.

Milos RI, Siegel MJ, Bluemke DA et al. · AJR. American journal of roentgenology · (2026) · 1 citations · View on PubMed ↗

---

---

Generated automatically on October 11, 2026. Covers PubMed articles published October 04, 2026 – October 11, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.